Neuropsychological sequelae of non-central nervous system cancer and cancer therapy.

Neuropsychology Review
Jeffrey S WefelChristina A Meyers

Abstract

Cancer patients report numerous adverse symptoms associated with their disease and treatment including cognitive dysfunction, fatigue, and affective distress. Cognitive dysfunction is ubiquitous in patients with primary central nervous system (CNS) cancer and recent evidence has documented similar deficits in patients with non-CNS cancer as well. Both the cancer itself and treatments including chemotherapy, biological response modifiers, and hormonal therapies have been demonstrated to adversely impact cognitive and neurobehavioral function. Neuroimaging and neurophysiological investigations have likewise revealed alterations in brain function that are helping to account for the nature of these cognitive disorders. Similarly, preclinical animal research is assisting to identify the pathophysiological mechanisms that underlie treatment-related neurotoxicities. The coalescence of multidisciplinary clinical and research efforts hold promise for the development of interventions that may offer neuroprotection in addition to currently available symptomatic therapies and cognitive rehabilitation techniques.

References

Nov 1, 1992·Cancer·M A AndrykowskiP J Henslee-Downey
Dec 1, 1992·Hormones and Behavior·S E McKennaA Cologer-Clifford
Jan 1, 1988·Psychopharmacology·A SmithP Higgins
Mar 1, 1982·Acta Pharmacologica Et Toxicologica·N WilkingN O Theve
Jul 1, 1995·Pediatric Hematology and Oncology·J García-TenaA Verdeguer
Jan 1, 1995·Cancer Investigation·A D ValentineM Talpaz
Jun 1, 1995·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·C A MeyersR Komaki
Apr 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C A MeyersD Przepiorka
May 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T A AhlesL Mills
Apr 1, 1997·The Journal of Neuropsychiatry and Clinical Neurosciences·D StriteC A Meyers
Mar 13, 1998·JAMA : the Journal of the American Medical Association·K YaffeD Grady
Jul 17, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C A MeyersV A Levin
Nov 10, 1998·Journal of Neurology·F Keime-GuibertJ Y Delattre
Aug 10, 1999·The Journal of Neuropsychiatry and Clinical Neurosciences·N MayrH Gisslinger
Oct 8, 1999·Journal of the National Cancer Institute·J E Groopman, L M Itri
Feb 8, 2000·International Journal of Radiation Oncology, Biology, Physics·M PeperM Wannenmacher
Jun 1, 2000·The American Journal of Psychiatry·E DieperinkS B Ho
Jun 2, 2000·Cancer Investigation·E Mihich
Jun 2, 2000·Clinical Chemistry and Laboratory Medicine : CCLM·J B Posner, J O Dalmau
Mar 10, 2001·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·R. T. PensonM. V. Seiden
Mar 29, 2001·The New England Journal of Medicine·D L MusselmanA H Miller
Mar 30, 2001·Clinical Nursing Research·C M BenderT Zullo
Jun 8, 2001·Proceedings of the National Academy of Sciences of the United States of America·M F EganD R Weinberger
Jun 30, 2001·The New England Journal of Medicine·C L Shapiro, A Recht
Oct 13, 2001·Cancer·U R MalikS Wadler
Mar 20, 2002·Pharmacology, Biochemistry, and Behavior·Duo ChenYong-Meng Xu
Jun 27, 2002·British Journal of Cancer·N TsavarisD Boulamatsis
Aug 22, 2002·Progress in Neuro-psychopharmacology & Biological Psychiatry·Martin SchaeferKlaus Lieb
Sep 7, 2002·Journal of Toxicology. Clinical Toxicology·Andrés AlcarazAlberto Medina
Oct 31, 2002·Cancer·Jesse R FannKaren L Syrjala
Dec 20, 2002·Canadian Journal of Physiology and Pharmacology·Sampath MadhyasthaK Laxminarayana Bairy
Jan 21, 2003·Clinical Breast Cancer·Sanne B SchagenFrits S A M Van Dam
Feb 5, 2003·Seminars in Clinical Neuropsychiatry·Andrew J Saykin, Heather A Wishart

❮ Previous
Next ❯

Citations

Jul 10, 2009·Current Pain and Headache Reports·Christopher Loiselle, Jason Rockhill
Jul 31, 2009·Journal of Clinical and Experimental Neuropsychology·Bernadine CimprichRobert C Welsh
Jan 11, 2011·Journal of Clinical and Experimental Neuropsychology·Philip G Gasquoine
May 12, 2010·Journal of the National Cancer Institute·Nina S Kadan-LottickKevin R Krull
Apr 23, 2013·Journal of the National Cancer Institute·Patricia A GanzThomas R Belin
Apr 23, 2013·Journal of the National Cancer Institute·Christina A Meyers
Dec 9, 2008·The Cancer Journal·Denise D Correa, Tim A Ahles
May 29, 2012·BMC Neurology·S M Hadi HosseiniShelli R Kesler
Oct 26, 2013·BMC Neurology·Justin DavisMustafa Khasraw
Aug 14, 2013·BMC Pharmacology & Toxicology·Adeline Rollin-SillaireEmilie Le Rhun
Jan 3, 2012·Journal of Oncology Practice·Malolan S RajagopalanYaacov R Lawrence
Jan 25, 2014·Brain Research·Leah M PyterBrian J Prendergast
Feb 12, 2014·Brain, Behavior, and Immunity·Miyoung YangChangjong Moon
Jun 28, 2012·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Silvia BernardiAda Francia
Jan 1, 2011·Occupational Therapy in Health Care·Mary F BaxterTheresa M Smith
Nov 19, 2011·Gynecologic Oncology·Denise D Correa, Lisa M Hess
Jul 30, 2010·Human Brain Mapping·Michiel B de RuiterSanne B Schagen
Jan 22, 2011·Psycho-oncology·Florence JolyBénédicte Giffard
Jan 17, 2013·Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging·Te-Chun HsiehChia-Hung Kao
Mar 2, 2010·Brain, Behavior, and Immunity·Leah M PyterBrian J Prendergast
May 8, 2013·The Breast : Official Journal of the European Society of Mastology·Lise PaquetShailendra Verma
Aug 14, 2012·Brain, Behavior, and Immunity·Patricia A GanzS W Cole
Apr 18, 2015·Journal of the National Cancer Institute·Kerstin HermelinkNadia Harbeck
Sep 28, 2010·Neuroscience and Biobehavioral Reviews·Riejanne Seigers, Joanna E Fardell
Jan 1, 2011·International Journal of Psychiatry in Medicine·Briana L ToddMichael Feuerstein
Mar 1, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Vincent KoppelmansSanne B Schagen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.